PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer

BACKGROUND: Although immune checkpoint blockade has emerged as a novel promising strategy for triple-negative breast cancer (TNBC), many patients fail response or acquire resistance to current agents. Consequently, our focus need to shift toward alternative inhibitory targets, predictor for responsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zheng, Li, Yaming, Wang, Xiaolong, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788839/
https://www.ncbi.nlm.nih.gov/pubmed/33407498
http://dx.doi.org/10.1186/s12935-020-01707-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788839/
https://www.ncbi.nlm.nih.gov/pubmed/33407498
http://dx.doi.org/10.1186/s12935-020-01707-9

Ejemplares similares